- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
IMA slams Health Minister Dr Harsh Vardhan over Patanjali Coronil claims
New Delhi: The Indian Medical Association (IMA) has expressed its shock at Yoga Guru Baba Ramdev's claims on Patanjali's Coronil as the "first evidence-based medicine for COVID-19", made in the presence of Union Health Minister, Dr Harsh Vardhan.
The Association called the claims of the Ayurvedic drug having DCGI approval and WHO certification a 'blatant lie' and has issued a statement seeking an explanation from Dr Harsh Vardhan for appearing to endorse the product.
The association has also decided to write to National Medical Commission (NMC) for seeking suo Moto explanation from the Minister for " his blatant disrespect to the code of conduct of Medical Council of India", as according to the MCI Code of ethics no doctor can promote any secret medication with a trading name. IMA has also criticized Baba Ramdev's comment on modern medicines in which he allegedly branded it as "medical terrorism."
This comes in the wake of the global health body, WHO, clarifying that it has not reviewed or certified the effectiveness of any traditional medicine for the treatment of COVID-19.
Medical Dialogues team had earlier reported that Patanjali issued a statement confirming that Coronil has received the Certificate of Pharmaceutical Product (CoPP) from the Ayush section of the Central Drugs Standard Control Organisation (CDSCO) as per the WHO certification scheme. The Ayush Ministry had classified it as an "Immuno-booster" only. The ministry earlier this month recognized Coronil as medicine for "supporting the measure in COVID-19" treatment, Ramdev had told reporters.
However, the World Health Organisation (WHO) sidelined itself and clarified in a tweet that it has not reviewed or certified any traditional medicine to treat or prevent COVID-19. Soon after the statement by WHO rejecting the claims was issued, Patanjali CEO Acharya Balkrishna made a clarification on Twitter and stated "WHO does not approve or disapprove any drugs. Instead, it works for building better and healthier future for people all over the world".
We want to clarify to avoid confusion that our WHO GMP compliant COPP certificate to Coronil is issued by DCGI, Government of India.
— Acharya Balkrishna (@Ach_Balkrishna) February 19, 2021
It is clear that WHO do not approve or disapprove any drugs.
WHO works for building a better, healthier future for people all over the world. pic.twitter.com/ZEDPdWy0tg
Sanchari Chattopadhyay has pursued her M.A in English and Culture Studies from the University of Burdwan, West Bengal. She likes observing cultural specificities and exploring new places.